De novo TANC2 stop‐loss variant associated with developmental impairment and drug‐resistant epilepsy
Epileptic Disorders · 2026-08 · 28 (4) · 1281-1284
DOI: 10.1002/epd2.70219 ↗Kurz gefasst
Fallbericht in der Zeitschrift Epileptic Disorders, online erschienen am 17.03.2026. Verfasst von Matthew A Hintermayer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
- Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
- Division of Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
- Department of Neurology and Neurosurgery, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
ORCID-Profile: Kenneth A Myers
Zitieren
APA
Hintermayer, M. A., & Myers, K. A. (2026). De novo TANC2 stop‐loss variant associated with developmental impairment and drug‐resistant epilepsy. Epileptic Disorders, 28(4), 1281-1284. https://doi.org/10.1002/epd2.70219
Vancouver
Hintermayer MA, Myers KA. De novo TANC2 stop‐loss variant associated with developmental impairment and drug‐resistant epilepsy. Epileptic Disorders. 2026;28(4):1281-1284. doi:10.1002/epd2.70219
BibTeX
@article{Hintermayer2026,
author = {Hintermayer, Matthew A and Myers, Kenneth A},
title = {De novo TANC2 stop‐loss variant associated with developmental impairment and drug‐resistant epilepsy},
journal = {Epileptic Disorders},
year = {2026},
volume = {28},
number = {4},
pages = {1281--1284},
doi = {10.1002/epd2.70219}
}
EUVIMED